Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

510 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer.
Honda C, Kurozumi S, Katayama A, Hanna-Khalil B, Masuda K, Nakazawa Y, Ogino M, Obayashi S, Yajima R, Makiguchi T, Oyama T, Horiguchi J, Shirabe K, Fujii T. Honda C, et al. Among authors: katayama a. Mol Clin Oncol. 2021 Dec;15(6):252. doi: 10.3892/mco.2021.2414. Epub 2021 Oct 8. Mol Clin Oncol. 2021. PMID: 34671471 Free PMC article.
Carboxypeptidase A4 accumulation is associated with an aggressive phenotype and poor prognosis in triple-negative breast cancer.
Handa T, Katayama A, Yokobori T, Yamane A, Fujii T, Obayashi S, Kurozumi S, Kawabata-Iwakawa R, Gombodorj N, Nishiyama M, Asao T, Shirabe K, Kuwano H, Oyama T. Handa T, et al. Among authors: katayama a. Int J Oncol. 2019 Mar;54(3):833-844. doi: 10.3892/ijo.2019.4675. Epub 2019 Jan 4. Int J Oncol. 2019. PMID: 30628666 Free PMC article.
β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer.
Kurozumi S, Kaira K, Matsumoto H, Hirakata T, Yokobori T, Inoue K, Horiguchi J, Katayama A, Koshi H, Shimizu A, Oyama T, Sloan EK, Kurosumi M, Fujii T, Shirabe K. Kurozumi S, et al. Among authors: katayama a. Breast Cancer Res Treat. 2019 Oct;177(3):603-610. doi: 10.1007/s10549-019-05341-6. Epub 2019 Jul 9. Breast Cancer Res Treat. 2019. PMID: 31290053
Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer.
Kurozumi S, Kaira K, Matsumoto H, Kurosumi M, Yokobori T, Kanai Y, Sekine C, Honda C, Katayama A, Furuya M, Shiino S, Makiguchi T, Mongan NP, Rakha EA, Oyama T, Fujii T, Shirabe K, Horiguchi J. Kurozumi S, et al. Among authors: katayama a. Sci Rep. 2022 Feb 17;12(1):2742. doi: 10.1038/s41598-022-06615-8. Sci Rep. 2022. PMID: 35177712 Free PMC article. Clinical Trial.
510 results